ABOS · Acumen Pharmaceuticals, Inc. · Investor Relations
$2.16
+0.03 (+1.41%)
At close · Oct 6
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Accordingly, management has concluded that substantial doubt exists regarding our ability to continue as a going concern.”View the 10-Q filed Aug 12, 2026
Market Cap
$159.46M
Shares
72.32M
Volume · Oct 5
713.98K
Avg daily vol (3M)
424.88K
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.